The genus Enterococcus like other LAB has also been featured in dairy industry for decades due to its specifi c biochemical traits such as lipolysis, proteolysis, and citrate breakdown, hence contributing typical taste and fl avor to the dairy foods. Furthermore, the production of bacteriocins by enterococci (enterocins) is well documented. These technological applications have led to propose enterococci as adjunct starters or protective cultures in fermented foods. Moreover, enterococci are nowadays promoted as probiotics, which are claimed for the maintenance of normal intestinal microfl ora, stimulation of the immune system and improvement of nutritional value of foods. At the same time, enterococci present an emerging pool of opportunistic pathogens for humans as they cause disease, possess agents for antibiotic resistance, and are frequently armed with potential virulence factors. Because of this 'dualistic' nature, the use of enterococci remains a debatable issue. However, based on a long history of safe association of particular enterococci with some traditional food fermentations, the use of such strains appears to bear no particular risk for human health. Abundance of knowledge as well as progress in molecular techniques has, however, enabled exact characterization and safety assessment of strains. Therefore, a balanced evaluation of both, benefi cial and undesirable nature of enterococci is required. A clear understanding of their status may, therefore, allow their safe use as a starter, or a probiotic strain. The present review describes the broader insight of the benefi ts and risks of enterococci in dairy foods and their safety assessment.
Introduction
The Enterococci are lactic acid bacteria (LAB) which form an important part of environmental, food and clinical microbiology. Depending on the strain, they are considered as starter or adjuncts starter, probiotics, spoilage, and pathogenic organisms. They play a benefi cial role in the development of the organoleptic characteristics of cheeses (especially those originating in the Mediterranean countries) and have been successfully used as starter and adjuncts cultures. Many enterococci also produce a diverse and heterogeneous group of ribosomally synthesized antimicrobial peptides or bacteriocins, known as enterocins [1, 2] . Enterocins usually belong to the Class II bacteriocins. Enterocins are peptide in nature and are often cationic, amphiphilic, membrane-permeabilizing molecules [3, 4] . Bacteriocins may inhibit pathogenic bacteria with a benefi cial impact as protective cultures [3] . In the same manner, enterococci are also acknowledged as contributors to human's digestibility and, therefore, are additionally known for their role as probiotics. Undesirable aspects among others may include the spoilage of foods and the production of biogenic amines [2, 5] .
However, some of the enterococcal strains are typical opportunistic pathogens that cause disease especially in the nosocomial settings. Moreover, due to the higher incidence of infections by enterococci in young, older and immunocompromised patients, and to their extended resistance to antibiotics, they are being considered as emerging pathogens [6, 7] . The majority of infections are caused by either E. faecalis or E. faecium strains, [8, 9] However, strains of E. gallinarum [10] , E. hirae [11] , and E. mundtii [12] have been also associated with endophtalmitis and native valve endocarditis in humans.
In addition, many enterococcal isolates of different origin carry potential virulence factors [13] [14] [15] . Which can be transferred through mobile genetic elements [16] . These also participate in molecular communication between bacteria of the animal and human microfl ora [17] , giving the enterococci a new dimension regarding their potential pathogenicity to immunocompromised persons. This dualistic nature of enterococci gives rise to concern in the food industry.
The Enterococci
Phylogeny and taxonomy of enterococci Enterococci were described for the fi rst time by Thiercelin in 1899 and genus Enterococcus was proposed by Thiercelin and Jouhaud in 1903 for the Gram positive diplococci of intestinal origin. Andrewes and Horder (1906), however, renamed Thiercelin's enterococci as Streptococcus faecalis based on their ability to form short or long chains. The species epithet 'faecalis' was suggested because of their close resemblance to strains isolated from the human intestine. This explains why the history of enterococci cannot be separated from that of the genus Streptococcus [18, 2] .
In 1933, a serological typing system, for enterococci was developed by Lancefi eld in which those of 'faecal origin' possessed the group D antigen [19] . This correlated with the grouping system of Sherman (1937) , which proposed a new classifi cation scheme for the genus Streptococcus that separated it into four divisions designated as pyogenic, viridans, lactis and 'enterococcus' [20] . The 'enterococcus' group included Streptococcus faecalis, Streptococcus faecium, Streptococcus bovis and Streptococcus equinus as the 'enterococcal' or group D strains.
The classical taxonomy of the enterococci is rather vague because there are no phenotypic characteristics that unequivocally distinguish them from other Gram-positive, catalase-negative, coccus-shaped bacteria [21] . The majority of Enterococcus species, however, can be distinguished from other Gram-positive, catalase-negative cocci by their ability to grow from 10 o C to 45 °C, survive heating at 62.8 °C for 30 min, tolerate 6.5 % NaCl and 40 % bile and grow between pH 4.0 and 9.6 [22] .
DNA-DNA hybridisation and 16S rRNA sequencing studies carried out by Schleifer and Kilpper-Ba¨lz (1984) [23] indicated that the species Streptococcus faecium and Streptococcus. faecalis were suffi ciently distinct from other streptococci, and they proposed their transfer to the genus Enterococcus. To date, 28 species of enterococci have been added to the genus on the basis of phylogenetic evidence strengthened by 16S rRNA-DNA sequencing and/ or DNA-DNA hybridization studies [2] .
Enterococci in dairy foods
Presence of enterococci in dairy foods can have confl icting effects, of either as a risk or as a foreign or intrusive fl ora indicating poor hygiene during milk handling and processing (if in excessive numbers), or as a benefi t in contributing to produce unique traditional and emerging by-products, in protecting against diverse spoilers, and as probiotics.
Enterococci as contaminants or natural starter in milk
Traditionally, the prevalence of enterococci in milk is considered as a result of faecal contamination. However, the ability of enterococci to grow in milking equipment, processing plants, and other environments, put in doubt the reliability of enterococcal counts as a refl ection of faecal contamination [24] . Mundt (1986) [25] also demonstrated that the common presence of E. faecalis in many food products is not always related to direct faecal contamination. Due to their psychotropic nature, heat resistance and adaptability to different substrate and growth conditions, they can grow during refrigeration and survive after pasteurization. Therefore, enterococci are a part of both raw and pasteurized milk microfl ora [26] . A study of the levels of enterococci in raw cow's milk from 10 New Zealand farms, revealed an enterococcal range from 10 1 cfu/ml to 1.2 x 10 4 cfu/ml [27] . Different species of enterococci are found in dairy products, but E. faecalis and E. faecium remain the species of greatest importance. E. faecalis is often the predominating over E. faecium [28, 29] . Other sources report numbers in European raw milk varying from 10 3 cells/ml to 10 5 cells/ml, or more, without any of the species being markedly represented. [30] In 1992, the European Union established a maximum level for the presence of coliforms and E. coli, both considered as indicators of hygiene, while no acceptable levels of enterococci can be stated for foods [31] . Furthermore, it has been shown that enterococci had little value as hygiene indicators in the industrial processing of foods [32] . Therefore, it is now accepted that enterococci naturally occur in raw milk and whey and act as a starter culture during manufacture of a variety of milk products. 
Functional properties of enterococci
From the positive side enterococci are closely involved in the production of traditional fermented foods and probiotic preparations. Enterococci show higher proteolytic activities than other LAB, which is important for cheese ripening. Their benefi cial effect in cheese making has also been attributed to hydrolysis of milk fat by esterases and production of fl avor components such as acetaldehyde, acetoin and diacetyl due to citrate breakdown. This benefi cial role of enterococci in the development of cheese aroma has led to the inclusion of enterococcal strains as starter cultures or starter adjuncts [28] . [64] has been shown as well. Two main applications concerning bacteriocins are possible: the use of either antimicrobial peptide as additives or bacteriocinogenic strains directly the in food system. Many reports consider possible use of enterocins/bacteriocinogenic enterococci as protective starters in different food models, where it can effi ciently serve as a barrier in a hurdle technology.
[65] Well-characterised enterocins are A, P, CRL35, 1071A, and B; bacteriocin 31, 32, RC714, and T8; enterolysin A, AS-48, EJ97, RJ11, Q, L50A and B [66] .
Enterocins with broad inhibitory spectra against food spoilage and pathogenic organisms undoubtedly indicate their use as biopreservative agents in dairy systems. As proposed by Giraffa (1995) , careful identifi cation followed by thorough testing based upon certain criteria must be accomplished before putting any of the enterocins (or enterocin producing strains) to practical use in the dairy industry [58] .
Therapeutic properties of enterococci are manifested through probiotic activities including maintenance of the normal intestinal microfl ora and thereby reduction of gastrointestinal disorders, alleviation of lactose intolerance, reduction in serum cholesterol levels, anticarcinogenic activity, stimulation of the immune system and improved nutritional value of foods [2] . Enterococci are important members of the microfl ora inhabiting GI tract of humans with E. faecalis, E. faecium and E. durans as prevailing species [67] . Therefore, Enterococcus spp. besides Lactobacillus spp. and Bifi dobacterim spp. are used as probiotics [5] .
A well-studied Enterococcus strain used as a probiotic is E. faecium SF 68, which is produced in Switzerland. It has been proposed to be clinically effective in the prevention of antibiotic-associated diarrhea [68] [77] used the strain E. faecium CRL 183 in combination with Lactobacillus jugurti for the development of a novel fermented soymilk product. This formulated product showed prominent hypocholesterolemic effect under in vitro trials. E. faecium PR88, another probiotic strain was studied in a human clinical trial which alleviated the symptoms of irritable bowel syndrome [78] . Likewise, Gardiner et al., (1999) [79] used E. faecium PR88 as adjunct starter for the production of a probiotic Cheddar cheese.
E. faecalis and E. faecium strains have also been widely used as veterinary feed supplements. Since February 2004, 10 preparations (9 different strains of E. faecium) are authorized as additives in feeding stuffs in the European Union (European Commission, 2004) [80] .
However, despite the well-established probiotic benefi ts of several enterococcal strains, the controversy that they may pose some risks for the human health has made the application of enterococci as probiotic within the food industry a debatable issue [65] .
Undesirable activities of enterococci
Besides their positive traits, several risk factors are also associated with enterococci. They can, therefore, become a problem in traditionally fermented food products especially if present initially in high numbers [81] . Production of biogenic amines seems to be unfavorable activity of enterococci in fermented dairy products, because biogenic amines have been associated with a number of food poisoning episodes [82] . It has been observed that the prolifi c growth of enterococci in milk and milk products leads to the formation of signifi cant levels of biogenic amines [4, 43, 83] . In fact, tyramine is the only relevant biogenic amine produced by enterococci isolated from dairy products [84] .
It is known that casein degradation performed by enterococci play an important role in the development of fl avor and texture in cheese. This statement could be true to the certain level as some peptides contribute to the fl avor; while others undesirable bitter-tasting peptides can lead to off-fl avors of cheese [65] . The lipolytic activity of enterococci in cheese contributes towards cheese fl avor due to the formation of fatty acids. Oxidation of these fatty acids, leads to the formation of methyl ketones and lactones which thereby form unsaturated and favored aldehydes causing a fl avour defect referred to as oxidative rancidity [2] .
More seriously, a number of nosocomial infections such as endocarditis, bacteraemia, urinary tract and neonatal infections have been also associated with an increasing incidence of enterococci, predominantly by the strains of E. faecalis and, to a lesser extent, E. faecium. Over the last two decades, enterococci, formerly viewed as organisms of minimal clinical impact, have emerged as opportunistic pathogens of humans [8] . Several virulence factors of enterococci have been described and the number of antibiotic resistant enterococci (ARE), especially vancomycin-resistant enterococci (VRE), is increasing [2] .
Virulence of enterococci
For enterococci to cause infection, they must fi rst colonize the host tissue, resist host specifi c and unspecifi c defense mechanisms, and produce pathological changes. [28] Known virulence traits in enterococci include aggregation substance (agg) , extracellular surface protein (esp) and adhesin-like E.faecalis and E.faecium antigens (efaAfs, efaAfm) which play a major role in adherence to host tissues. Besides these, secretion of cytolysin (cyl), other toxic products as gelatinase (gelE), hyaluronidase and production of plasmid-encoded sex pheromones (cpd, cob, ccf, cad) are also considered as virulence traits. Cytolysins are responsible for lysing a broad range of eukaryotic and prokaryotic cells, while gelatinase (gelE) acts on collagenous material in tissues and facilitates in invasion. Sex pheromone facilitates the conjugation mediated uptake of antibiotic resistance and virulence traits [5, 13] .
Some enterococci possess a plasmid collection mechanism which is based on production of chromosomally encoded 'sex pheromones'. Sex pheromones are small, linear peptides of 7 or 8 amino acids that are excreted by E. faecalis strains which promote the acquisition of plasmid DNA. When pheromones bind to receptors on the cell surface of strains that contain plasmid DNA, this signal is transduced and leads to induction of the aggregation substance (AS) gene. When this gene expresses, AS mediates the formation of cell clumps by binding to a complementary receptor termed binding substance, that allows the highly effi cient transfer of the pheromone plasmid on which the AS gene is encoded [85, 86] . The pheromones, however, not only have a role in transfer of plasmid DNA, but also serve as chemo-attractive substances for human neutrophils and induce infl ammation and superoxide production [87, 88] .
Gelatinase is an extracellular metallo-endopeptidase involved in hydrolysis of gelatin, collagen, and other bioactive peptides [89] . The production of gelatinase was shown to increase pathogenicity in an animal model, [90] which confi rms its role in virulence. Enterococcal lipoteichoic acid from the cell wall was shown to induce production of interleukin-1β, interleukin-6 and TNF-α in vitro and may, therefore, contribute to local tissue damage. Hyaluronidase is a cell surface-associated enzyme which cleaves the mucopolysaccharide moiety of connecting tissues or cartilage. This enzyme has been implicated to act as 'spreading factor' for dissemination of some microorganisms [88] .
Virulence factors are mainly detected among clinical enterococcal isolates, although studies done on the prevalence of virulence traits among enterococcal strains isolated from food suggest that some strains harbour virulence traits as well [5] . In this regard Eaton and Gasson (2001) [13] showed that enterococcal virulence factors were present in clinical, food and starter culture isolates and the prevalence was higher among clinical strains, followed by food isolates; the lowest prevalence was observed for starter isolates. Among enterococcal species, E. faecalis generally harbour more and multiple virulence determinants and in E. faecium the frequencies was very low [6, 13, 91] .
Antibiotic resistance
Virulence of enterococci is strongly enhanced by their frequent resistance to commonly used antibiotics, which makes them effective opportunists in nosocomial infections [81] . Antibiotic resistance encompasses both natural (intrinsic) resistance and acquired (transferable) resistance. Enterococci possess a broad spectrum of antibiotic resistances within these two types [92] . Examples of intrinsic antibiotic resistance include resistance to cephalosporins, β-lactams, sulphonamides and low levels of clindamycin and aminoglycosides, while examples of acquired resistance include resistance to chloramphenicol, erythromycin, high levels of β-lactams, fl uoroquinolones and glycopeptides, such as vancomycin [5] .
Vancomycin resistance is of special concern because emergence of vancomycin resistant enterococci (VRE) in hospitals has led to serious infections that cannot be treated with conventional antibiotic therapy. Six different gene clusters mediating glycopeptide resistance have been described in enterococci: vanA, vanB, vanD, vanE and vanG which are known to be acquired traits, while vanC is an intrinsic property of motile enterococci. The vanA type of enterococcal glycopeptide resistance is the most important one and its main reservoir is E. faecium [92] .
After considering the positive and negative attributes of this genus, the question whether enterococci are safe for use as starter cultures remains diffi cult to answer. The principal concern for enterococci in the food is their pathogenic potential based on horizontal transfer of genes for factors associated with virulence and antibiotic resistance. With in vitro studies, Eaton and Gasson (2001) [13] were able to show that virulence genes on a pheromone-responsive plasmid could be transferred to strains of E. faecalis used as starter cultures in food, but they were not able to transfer virulence genes into strains of E. faecium starter cultures. Though the food chain has clearly been established as an important source of enterococci in human environment, where some strains may bear antibiotic resistance and virulence traits. The present evidence, however, does not suggest enterococci as food borne pathogens. The control and safety of foods that contain enterococci is a special challenge to food industry because of their robust nature, their wide distribution and their stability in the environment.
Safety assessment of enterococci
The increasing number of enterococcal infections in recent decades has raised questions regarding their use in foods and probiotics. Studies on the incidence of virulence traits showed that food isolates can also harbour such traits [6, 13] . Thus, before using enterococci for food production or in probiotic preparations, safety of these strains should be evaluated. Recently, many authors have assessed the safety of enterococci isolated from different origins [93] [94] [95] [96] [97] . Safe strains of enterococci that can be used in food and as probiotics ideally should possess neither any of virulence factors, nor should be able to acquire antibiotic resistance gene [8] . Furthermore, biogenic amines producing strains are also not preferable in food [82] . Opsonophagocytic killing is considered to be additional and an important test to assess the safety of enterococcal strains. It is used as an in vitro test to detect a protective immune response of host against enterococci [98, 99] . On the basis of all these tests the proper selection of enterococci for use in food industry is possible.
Conclusion
Enterococci are widely present in nature and dairy products. They can grow in a cheese environment and develop typical taste and fl avor in traditional Mediterranean cheeses. Some strains of enterococci produce bacteriocins inhibitory against spoilage or pathogenic bacteria. Therefore, they can be used as starter or adjuncts starter as well as protective cultures in dairy industry. Enterococci also have been used as probiotics because of their possible health-promoting capabilities. However, very few enterococci isolated from dairy products, carry potential virulence factors and can display pathogenic traits. Furthermore, the number of VRE has been increasing during the last decade. Fortunately, these important features are strain-dependent. For these reasons, the selection of Enterococcus strains of interest in the food industry should be based on the absence of any possible pathogenic properties, or transferable antibiotic resistance genes. Modern analysis techniques as well as up-to-date knowledge of these strains and their properties will help the food processor and the consumer to accept enterococci like other LAB as important players in certain food and dairy products. 
